These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Albanesi C; De Pità O; Girolomoni G Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896 [TBL] [Abstract][Full Text] [Related]
6. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Späh F Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910 [TBL] [Abstract][Full Text] [Related]
7. Three decades of psoriasis research: where has it led us? Sabat R; Sterry W; Philipp S; Wolk K Clin Dermatol; 2007; 25(6):504-9. PubMed ID: 18021885 [TBL] [Abstract][Full Text] [Related]
8. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Zhou X; Krueger JG; Kao MC; Lee E; Du F; Menter A; Wong WH; Bowcock AM Physiol Genomics; 2003 Mar; 13(1):69-78. PubMed ID: 12644634 [TBL] [Abstract][Full Text] [Related]
9. [The pathogenesis of inflammatory dermatoses, especially psoriasis]. Bos WE; Thio HB; Neumann HA; van der Fits L; Prens EP Ned Tijdschr Geneeskd; 2006 Jan; 150(4):179-83. PubMed ID: 16471231 [TBL] [Abstract][Full Text] [Related]
10. Psoriasis: Keratinocytes or Immune Cells - Which Is the Trigger? Benhadou F; Mintoff D; Del Marmol V Dermatology; 2019; 235(2):91-100. PubMed ID: 30566935 [TBL] [Abstract][Full Text] [Related]
11. Scanning the Immunopathogenesis of Psoriasis. Chiricozzi A; Romanelli P; Volpe E; Borsellino G; Romanelli M Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316717 [TBL] [Abstract][Full Text] [Related]
12. Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis. Tonel G; Conrad C Int J Biochem Cell Biol; 2009 May; 41(5):963-8. PubMed ID: 19027868 [TBL] [Abstract][Full Text] [Related]
13. New trends in the immunopathogenesis of psoriasis. Kastelan M; Massari LP; Pasić A; Gruber F Acta Dermatovenerol Croat; 2004; 12(1):26-9. PubMed ID: 15072745 [TBL] [Abstract][Full Text] [Related]
14. The roles of cells and cytokines in the pathogenesis of psoriasis. Coimbra S; Figueiredo A; Castro E; Rocha-Pereira P; Santos-Silva A Int J Dermatol; 2012 Apr; 51(4):389-95; quiz 395-8. PubMed ID: 22435425 [TBL] [Abstract][Full Text] [Related]
15. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24. Wang F; Smith N; Maier L; Xia W; Hammerberg C; Chubb H; Chen C; Riblett M; Johnston A; Gudjonsson JE; Helfrich Y; Kang S; Fisher GJ; Voorhees JJ Br J Dermatol; 2012 Jul; 167(1):92-102. PubMed ID: 22458549 [TBL] [Abstract][Full Text] [Related]
16. Cellular sources of IL-17 in psoriasis: a paradigm shift? Keijsers RR; Joosten I; van Erp PE; Koenen HJ; van de Kerkhof PC Exp Dermatol; 2014 Nov; 23(11):799-803. PubMed ID: 25039885 [TBL] [Abstract][Full Text] [Related]
17. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Vollmer S; Menssen A; Trommler P; Schendel D; Prinz JC Eur J Immunol; 1994 Oct; 24(10):2377-82. PubMed ID: 7925564 [TBL] [Abstract][Full Text] [Related]